Pharmacy Compact States List 2026: Where Multistate Pharmacist Licensure Actually Stands

Interactive Map: Pharmacy vs. Other Healthcare Compacts

Use the toggle below to compare pharmacy's compact status against nursing, physician, and psychology compacts. The contrast tells the story — every other major healthcare profession has an active interstate compact. Pharmacy has zero participating states.

Why Is There No Pharmacy Compact in 2026?

Pharmacy is one of the last major healthcare professions without an interstate licensure compact. At the 118th NABP Annual Meeting in June 2022, delegates passed a resolution directing NABP to examine the feasibility of a multistate licensure framework. Three years later, the result is not a compact in the traditional sense but an Interstate Pharmacist Practice Privilege (IPPP) model — a voluntary, NABP-administered framework that would let qualified pharmacists practice across participating states without obtaining full licensure in each one.

The distinction matters. A compact (like the Nurse Licensure Compact) is a binding interstate agreement enacted through identical legislation in each member state, governed by a commission. NABP's IPPP model is built on top of existing infrastructure — the Electronic Licensure Transfer Program (eLTP) and NABP Verify — and does not require states to cede any regulatory authority.

Why Has Pharmacy Fallen Behind?

Several factors have slowed pharmacy's path to multistate licensure:

1. Jurisprudence variation — Pharmacy law differs significantly across states, particularly around controlled substance dispensing, collaborative practice agreements, and scope of practice.
2. Board resistance — State boards of pharmacy maintain significant regulatory revenue from individual licensure fees and have been cautious about frameworks that could reduce oversight.
3. Scope of practice expansion — With pharmacists gaining prescribing authority, vaccine administration rights, and test-and-treat capabilities at different rates, a compact must account for widely varying scopes.
4. Controlled substance complexity — DEA registration is already federal, but state-level controlled substance regulations add layers that don't map cleanly onto a single multistate credential.

For a deeper look at how federal workforce policy intersects with pharmacy licensure portability, see our federal healthcare workforce policy report.

How Does the NABP Interstate Practice Privilege Model Work?

The IPPP model, still under development as of April 2026, operates on these core principles:

• Voluntary state adoption — Each state decides whether to participate by enacting model legislation.
• Home state licensure required — Pharmacists must hold an active, unrestricted license in their home state.
• Practice privilege, not licensure — Pharmacists receive a privilege to practice in participating states, not a separate license.
• Built on eLTP and NABP Verify — Credential verification uses existing NABP systems rather than creating a new commission.
• States retain disciplinary authority — Any participating state can restrict or revoke the privilege for practice occurring within its borders.

IPPP vs. Traditional Compact: Key Differences

Which Healthcare Professions Already Have Interstate Compacts?

Pharmacy's absence from this list creates real barriers for telepharmacy operations, disaster-response deployment, and pharmacists who relocate or practice near state borders — as Pharmacy Times has reported.

What Can Pharmacists Do Right Now for Multistate Practice?

Until the IPPP model is enacted, pharmacists seeking to practice in multiple states have three options.

1. NABP Electronic Licensure Transfer Program (eLTP)

The eLTP handles over 10,000 license transfer requests annually across all 54 NABP member boards. It streamlines — but does not eliminate — the process of obtaining licensure in additional states.

Steps to transfer via eLTP:

1. Log in to your NABP e-Profile.
2. Select the target state(s) for licensure transfer.
3. NABP electronically transmits your credentials and NAPLEX/MPJE scores to the receiving board.
4. Complete any additional state-specific requirements (background check, application fee, jurisprudence exam).
5. Receive licensure from the target state board — timelines vary from 2 to 12 weeks depending on the state.

2. Uniform MPJE (Launching June 2026)

The Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE) is the most significant near-term development. Under the current system, pharmacists must pass a separate MPJE for every state. The UMPJE replaces this with a single exam covering federal pharmacy law and uniform state standards.

Early adopter states (effective April 1, 2026):

• Arizona
• Iowa

The UMPJE does not create a compact or multistate license. But it removes one of the most significant barriers — the cost and time of taking multiple jurisprudence exams — and lays groundwork for the IPPP model.

3. State-Specific Reciprocity and Endorsement

Most states offer licensure by reciprocity or endorsement for pharmacists already licensed elsewhere. Requirements vary significantly:

Pharmacists navigating these multi-state requirements can use RxAgent's AI-powered regulation lookup to verify state-specific licensing rules and practice restrictions across all 50 states — instead of checking each board of pharmacy website individually.

How Does This Affect Telepharmacy and Remote Practice?

The absence of a pharmacy compact has outsized consequences for telepharmacy. A pharmacist conducting remote drug utilization reviews, medication therapy management, or clinical consultations across state lines must hold licensure in each state where the patient is located.

This creates operational friction for:

• Telepharmacy platforms serving patients in 20+ states that must credential pharmacists accordingly
• Health systems with facilities spanning multiple states
• Mail-order and specialty pharmacies processing prescriptions from out-of-state prescribers
• Disaster response — during COVID-19, temporary emergency waivers were necessary because no standing compact existed

As Pharmacy Times has noted, advancing multistate licensure is vital to sustaining telehealth-era pharmacy services.

What States Are Most Likely to Adopt the IPPP Model First?

NABP has not published a formal list of target states. However, based on regulatory signals, the states most likely to adopt early are those that:

• Already participate in eLTP with streamlined reciprocity processes
• Have adopted or plan to adopt the Uniform MPJE
• Have active telepharmacy regulations showing openness to cross-border practice
• Participate in multiple other healthcare compacts (signaling legislative comfort with interstate frameworks)

States to watch include those in the CSG National Center for Interstate Compacts database that have enacted five or more healthcare compacts, as they have established legislative pathways for this type of model.

Timeline: What to Expect Next

Timeline estimates beyond June 2026 are projections based on NABP public communications and typical legislative cycles. No firm dates have been announced.

How Does Pharmacy Compare to Other Compact-Eligible Professions for Prescribers?

For NPs, PAs, and other prescribers working alongside pharmacists in collaborative practice settings, understanding the compact landscape across professions is critical. Our analysis of clinical reference tool alternatives covers how different platforms handle multi-state regulatory content for prescribers managing these complexities.